{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:15:04Z","timestamp":1790021704031,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005241","name":"Institut de Recherche Clinique De Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jacl.2021.05.006","type":"journal-article","created":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T10:26:31Z","timestamp":1622370391000},"page":"602-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-128X","authenticated-orcid":false,"given":"Manon","family":"Fantino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7555-1275","authenticated-orcid":false,"given":"Martine","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2021.05.006_bib0001","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=23294. ANKS1A ankyrin repeat and sterile alpha motif domain containing 1A [Homo sapiens (human)]: National Center for Biotechnology Information, U.S. National Library of Medicine; Last accessed: 2020\/10\/28."},{"issue":"23","key":"10.1016\/j.jacl.2021.05.006_bib0002","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1128\/MCB.00794-07","article-title":"Identification of phosphotyrosine binding domain-containing proteins as novel downstream targets of the EphA8 signaling function","volume":"27","author":"Shin","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.jacl.2021.05.006_bib0003","doi-asserted-by":"crossref","first-page":"e64817","DOI":"10.1371\/journal.pone.0064817","article-title":"Odin (ANKS1A) modulates EGF receptor recycling and stability","volume":"8","author":"Tong","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jacl.2021.05.006_bib0004","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1128\/MCB.01605-09","article-title":"The SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptors","volume":"30","author":"Kim","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jacl.2021.05.006_bib0005","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1038\/ncomms12799","article-title":"Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis","volume":"7","author":"Lee","year":"2016","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.jacl.2021.05.006_bib0006","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1582-4934.2012.01612.x","article-title":"Eph receptors and ephrins as targets for cancer therapy","volume":"16","author":"Xi","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jacl.2021.05.006_bib0007","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-811X-6-7","article-title":"Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells","volume":"6","author":"Emaduddin","year":"2008","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.jacl.2021.05.006_bib0008","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar3101","article-title":"Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus","volume":"12","author":"Kariuki","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.jacl.2021.05.006_bib0009","first-page":"1205","article-title":"Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci","volume":"26","author":"Molineros","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.jacl.2021.05.006_bib0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.biopsych.2011.02.028","article-title":"A quantitative-trait genome-wide association study of alcoholism risk in the community: findings and implications","volume":"70","author":"Heath","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.jacl.2021.05.006_bib0011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jacl.2021.05.006_bib0012","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Deloukas","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jacl.2021.05.006_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12933-018-0705-0","article-title":"Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes","volume":"17","author":"Charmet","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"45","key":"10.1016\/j.jacl.2021.05.006_bib0014","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacl.2021.05.006_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOL.0000000000000487","article-title":"Familial hypercholesterolemia: experience from the French-Canadian population","volume":"29","author":"Paquette","year":"2018","journal-title":"Curr Opin Lipidol"},{"issue":"20","key":"10.1016\/j.jacl.2021.05.006_bib0016","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.jacl.2021.05.006_bib0017","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jacl.2021.05.006_bib0018","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0022-2275(20)42605-7","article-title":"Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia","volume":"31","author":"Innerarity","year":"1990","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.jacl.2021.05.006_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jacl.2021.05.006_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.jacl.2021.05.006_bib0021","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.jacl.2021.05.006_bib0022","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacl.2021.05.006_bib0023","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jacl.2020.07.008","article-title":"The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia","volume":"14","author":"Paquette","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.jacl.2021.05.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2017.07.008","article-title":"Cardiovascular disease in familial hypercholesterolemia: validation and refinement of the Montreal-FH-SCORE","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2021.05.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2017.03.019","article-title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.jacl.2021.05.006_bib0026","first-page":"1312","article-title":"Scavenger receptor LOX1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia","volume":"33","author":"Paquette","year":"2017","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2021.05.006_bib0027","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/hr.2017.87","article-title":"Genetic risk factors influence nighttime blood pressure and related cardiovascular complications in patients with coronary heart disease","volume":"41","author":"Wirtwein","year":"2018","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacl.2021.05.006_bib0028","unstructured":"https:\/\/www.snpedia.com\/index.php\/Rs17609940. rs17609940: SNPedia; Last accessed: 2020\/10\/28."},{"issue":"16","key":"10.1016\/j.jacl.2021.05.006_bib0029","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacl.2021.05.006_bib0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jacl.2017.01.012","article-title":"The 9p21. 3 locus and cardiovascular risk in familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"52","key":"10.1016\/j.jacl.2021.05.006_bib0031","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1038\/sj.onc.1205988","article-title":"Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases","volume":"21","author":"Pandey","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jacl.2021.05.006_bib0032","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mam.2017.09.005","article-title":"Platelet-derived growth factor-C and -D in the cardiovascular system and diseases","volume":"62","author":"Lee","year":"2018","journal-title":"Mol Aspects Med"},{"issue":"4","key":"10.1016\/j.jacl.2021.05.006_bib0033","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cytogfr.2004.03.004","article-title":"PDGF and cardiovascular disease","volume":"15","author":"Raines","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"10.1016\/j.jacl.2021.05.006_bib0034","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.115.306566","article-title":"Genetics of coronary artery disease","volume":"118","author":"McPherson","year":"2016","journal-title":"Circ Res"},{"issue":"7293","key":"10.1016\/j.jacl.2021.05.006_bib0035","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.322.7293.1019","article-title":"Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality studyCommentary: Role of other genes and environment should not be overlooked in monogenic disease","volume":"322","author":"Sijbrands","year":"2001","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jacl.2021.05.006_bib0036","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOL.0000000000000519","article-title":"Predicting cardiovascular disease in familial hypercholesterolemia","volume":"29","author":"Paquette","year":"2018","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2021.05.006_bib0037","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int J Cardiol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421000775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421000775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:36:04Z","timestamp":1761831364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287421000775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1933287421000775"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2021.05.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2021.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}